Alcohol use is common among people infected with HIV and may contribute to adverse consequences such as reduced adherence to treatment regimens and increased likelihood of risky sexual behaviors. Therefore, researchers and clinicians are looking for treatment approaches to reduce harmful alcohol consumption in this population. However, clinical trials of existing treatment models are scarce. A literature review identified only 11 studies that included HIVinfected patients with past or current risky alcohol use and which targeted alcohol use and other health behaviors. Four studies focusing on HIVinfected participants with alcohol problems found mixed effects on adherence and on alcohol use. Five clinical trials included at least 10 percent of HIVinfected subjects who use alcohol; of these, only one reported significant evidence of a favorable impact on alcohol consumption. Finally, two trials targeting alcohol users at high risk for HIV infection identified treatment effects that were not sustained. Taken together, these findings provide limited evidence of the benefit of behavioral interventions in this population. Nevertheless, these studies give some guidance for future interventions in HIVinfected patients with alcohol problems.
I
n the United States, people infected with the human immunodeficiency virus (HIV) drink more alcohol than people in the general population. Specifically, a higher proportion drink risky amounts 1 or have an alcohol use disorder (i.e., abuse or dependence) (Conigliaro et al. 2003; Galvan et al. 2002; Lefevre et al. 1995; Samet et al. 2003a Samet et al. ,b, 2004 . Risky alcohol use in HIVinfected people has been associated with the following range of adverse effects:
• Reduced adherence to medication regimens for treatment of HIV infection (Chander et al. 2006; Conen et al. 2009; Cook et al. 2001; Golin et al. 2002; Halkitis et al. 2003; );
• Lack of a health care provider for the HIV infection (Metsch et al. 2009 );
• Delayed linkage to HIV medical care (Samet et al. 1998 );
• Increase in risky sexual behaviors (Kalichman et al. 2002; Metsch et al. 2009 );
• Increased transmission of sexually transmitted infections (Kalichman et al. 2000) ; and
• Progression of HIV disease (Conigliaro et al. 2003; Miguez et al. 2003; Samet et al. 2007 ).
Given the spectrum of problems associated with such alcohol use among HIVinfected patients, one important avenue to improving the health of this population is to develop interventions 1 According to the National Institute on Alcohol Abuse and Alcoholism (2007) , women who drink more than 3 drinks per day or more than 7 drinks per week and men who drink more than 4 drinks per day or more than 14 drinks per week are at increased risk for alcoholrelated problems. Alcohol consumption levels above these limits are considered risky drinking.
that target alcohol use and its associated consequences. Accordingly, interventions have been designed to both decrease alcohol consumption and address the specific adverse health consequences.
The concept that negative conse quences of alcohol use can be reduced in patients with HIV infection is based on research demonstrating the impact of clinical interventions on alcohol consumption and associated negative consequences in patients without HIV infection (Institute of Medicine 1990; Kristenson et al. 1983) . Alcohol research over the past three decades has demonstrated that behav ioral interventions can be effective, with benefits varying based on setting, severity of alcohol problems, and patient characteristics. For example, metaanalyses of randomized controlled trials (RCTs) 2 of interventions to reduce risky alcohol use demonstrated decreased drinking for patients in pri mary care settings (Beich et al. 2003; Kaner et al. 2007 ). However, no such effects were found in metaanalyses of interventions delivered in hospital settings (Emmen et al. 2004) , possi bly because inpatients typically have greater severity of alcohol problems (i.e., most are alcohol dependent) (Saitz et al. 2007 (Saitz et al. , 2008 . Several highquality RCTs of brief interventions delivered in emergency departments also detected no or limited benefit (D'Onofrio and Degutis 2002; Daeppen et al. 2007; Longabaugh et al. 2001; Monti et al. 1999) . The influence of the patient's consumption levels also was demon strated in several studies. For example, in two separate RCTs in the primary care setting (Fleming et al. 1997; Ockene et al. 1999) , where patients were seeking medical care but not necessarily for an alcohol problem, implementation of a 5 to 15minute discussion reduced alcohol consump tion in patients who met the criteria for risky drinking. Studies of such brief interventions among patients who met the criteria for alcohol dependence, however, have shown no benefit (Kaner et al. 2007; Whitlock et al. 2004; Wutzke et al. 2002) .
For alcoholdependent patients, more extensive behavioral interventions (e.g., cognitive-behavioral coping skills, motivational enhancement, 12step facilitation) can be effective (Project MATCH Research Group 1997) . In addition, several medica tions (i.e., disulfiram, naltrexone, and acamprosate) are approved for the treatment of alcohol dependence, and other medications (e.g., topiramate) are being further evaluated (Anton et al. 2006; Garbutt et al. 2005; Kranzler and Van Kirk 2001; Olmsted and Kockler 2008; Rubio et al. 2001) .
Given the strong evidence that alcohol consumption is an important health issue for many people with HIV infection, efforts to potentially ameliorate these problems by addressing alcohol use are of great interest. The studies in non-HIVinfected people reviewed above suggest that interven tions among HIVinfected people with alcohol problems could be beneficial. However, the wide range of results in these intervention studies based on setting and disease severity argues for the need to carefully assess efforts to mitigate alcohol's deleterious impact on health in HIVinfected patients. As an important step in this direction, this article summarizes the findings of a review of the clinical trial literature on interventions addressing alcohol con sumption and its consequences among HIVinfected patients. After describing the design of the literature search and evaluation, the article reviews the findings of the studies identified and discusses the implications of those findings.
Design of the Literature Review
The literature review sought to identify clinical trials of interventions among HIVinfected people with past or current unhealthy alcohol use (i.e., the spectrum from risky drinking to alcohol dependence [Saitz 2005] ) that reported effects on any of the following outcomes:
• HIV disease progression;
• Receipt of HIV treatment;
• HIV medication adherence;
• HIV risk behaviors;
• Acquisition of sexually transmitted infections; and
• Alcohol use.
To be included in the review, the studies had to report alcoholspecific outcomes. Beyond that, the studies were classified into three categories of specificity. The most specific category comprised clinical trials that included only HIVinfected people with past or current unhealthy alcohol use. The second category comprised clinical trials that included only HIVinfected people but in which not all of the participants exhibited unhealthy alcohol use. For a study to be included in this category, at least 10 percent of partic ipants had to report current alcohol use. The third category of studies comprised trials that were aimed at preventing alcohol use and sexual behaviors that put people at risk of HIV infection among alcoholusing people. Although these studies did not include HIVinfected participants or did not report the HIV status of the participants, they were reviewed because they may inform future research on people at risk of HIV transmission in the setting of alcohol use.
Initially, the review intended to include only RCTs. However, very few studies were identified that met this criterion in the first two categories. Therefore, the search was expanded to include nonrandomized and non controlled clinical intervention trials in categories 1 and 2.
To identify relevant studies, the literature database MEDLINE was searched through September 30, 2009, using the search terms "HIV, alcohol, hazardous drinking, risky drinking, problem drinking, counseling, brief intervention, 12 step, pharma cotherapy, naltrexone, acamprosate, disulfiram, topiramate, and clinical trial." For all articles identified using this approach, the reference lists also 2 RCTs are clinical studies in which patients randomly are assigned to either one or more groups receiving the treatment under investigation or to a control group receiving no treatment or a treatment of known efficacy.
were scanned, as were related articles identified by the search engine for the MEDLINE data base to look for additional studies. Reference lists for articles that were closely related, but did not meet the criteria, also were reviewed. Finally, articles referenced in relevant review articles were examined. Titles of all articles were reviewed to determine if the articles met the selec tion criteria. If the nature of the study could not be discerned through the title, the abstract and/or full text of the article was retrieved and reviewed.
For all studies that met the criteria for one of the three categories, infor mation on the setting, study design, methodological quality, type of inter vention, outcomes reported, period of followup, and results was extracted. The following sections summarize the findings of these analyses. They are presented as a descriptive narrative synthesis because studies were too few and heterogeneous to perform a standard metaanalysis.
Results of the Literature Review
The search strategy described above identified 241 potentially relevant studies that were evaluated further. Of these, four studies including a total of 578 patients (Aharonovich et al. 2006; Parsons et al. 2007; Samet et al. 2005; Velasquez et al. 2009 ) met the selection criteria for the first category (see table  1 ). Another five clinical trials that included 1,311 patients (Gilbert et al. 2008; NaarKing et al. 2006 NaarKing et al. , 2008 RotheramBorus et al. 2001 RotheramBorus et al. , 2009 Sorensen et al. 2003) fell into the second category. In addition, two informative studies of interventions among people at highrisk for HIV reported outcomes specific to alcohol use (Kalichman et al. 2008; Morgenstern et al. 2007) . All of these studies are reviewed below. Some other studies that involved alcohol using, HIVinfected patients, but were excluded from this discussion because of serious design or methodological limitations, are listed in Table 2 (Prochaska and DiClemente 1982) . In contrast, the control group received educational materials on HIV and alcohol, referral information, and advice to stop or cut back on their alcohol use. At the 12month followup, the investigators determined some benefits of the intervention on some of the measures evaluated. For example, the control group had 1.4 times the num ber of drinks per 30 days and 1.5 times the number of heavydrinking days per 30 days compared with the interven tion group. For other measures (e.g., having anal sex without a condom, number of drinking days, or number of days on which both drinking and sex occurred), however, no significant difference existed between the two groups. Only when the analysis of sameday drinking and sex was restricted to participants who had shown this behavior at baseline, did those in the control group have significantly (i.e., 2.19 times) more days on which drink ing and sex occurred than the interven tion group. The interpretation of these findings is limited by the fact that there was differential loss to followup-that is, the analyses included only 81 percent of participants randomized to the intervention group and 90 percent of subjects randomized to the control group. Thus, one cannot exclude the possibility that particularly in the intervention group, participants with worse outcomes were not included in the analysis.
Aharonovich and Colleagues (2006)
Study. In this pilot study, 31 HIV infected primarycare patients with heavy alcohol use received one session of MI from a trained counselor, fol lowed by daily telephonebased interac tive voice response (IVR) assessments of drinking amounts and graphic feed back of changes in drinking at 30 and 60 days. This intervention resulted in a decrease in the number of drinks per day at 30 and 60 days (from 3.2 drinks per day at baseline to 1.7 drinks at 30 days and 1.2 drinks at 60 days). The IVR system was utilized; 77 percent of all possible daily calls were completed at 30 days. However, these improve ments can not be attributed to the intervention with confidence because there was no control group.
Parsons and Colleagues (2007)
Study. These investigators conducted an RCT among 143 HIVinfected peo ple with "hazardous drinking" (defined as more than 16 standard drinks per week for men or more than 12 standard drinks per week for women), assessing treatment effects on HIV medication adherence and alcohol outcomes. The intervention involved eight 1hour individual sessions of MI and cognitive behavioral skills training over 3 months and was compared with a time and contentequivalent control. 4 Over the 3 The transtheoretical model (TTM) is a health behavior theory that assesses the individual's readiness to change a particular behavior in order to facilitate the desired behavior change. The stages of change are: precontemplation, contemplation, preparation, action, and maintenance.
in that group spend the same amount of time with a health care provider/therapist as the intervention group, and they receive the same type of information. The only difference between the inter vention and control groups is the method used to deliver the information, allowing researchers to determine whether one approach is more effective than the other.
followup period (3 and 6 months), both groups exhibited substantial improvement for both total alcohol drinks over 14 days or drinks per drinking day, although no significant differences existed between the inter vention and the control group. However, compared with the control group, the intervention did improve medication adherence, number of virus particles detectable in the blood (i.e., viral load), and CD4 cell 5 counts at 3 months. These statistically significant improve ments were not sustained at 6 months.
5 CD4 cells are a type of white blood cell that is the main target of the HIV virus; accordingly, levels of these cells in the blood decline with progressing HIV infection and are a marker for disease progression.
Samet and Colleagues (2005) Study.
This RCT included 151 HIVinfected patients on antiretroviral therapy (ART) who had a history of alcohol problems. The participants received either four nursedelivered, 30 to 60minute sessions focusing on HIV medication adherence and alcohol counseling, both in a clinic Number of HIV negative partners and risky sexual acts also was reduced.
Subanalysis of a clinical trial (Wong et al. 2008):
5% used alcohol/ marijuana in the parent study. Proportion of alcohol users at baseline not presented in this study.
Parent study reported only transmission act outcomes and demonstrated an effect that was not maintained at 25 months. number of days using alcohol or marijuana in the last 90 was 37.
Imbalance in transmission risk acts at baseline Setting: Recruited from community agencies, medical clinics, and advertisements. resulted in ineffective randomization, thus propensity scores were used to adjust for imbalances. maximum number of drinks. Moreover, in the final analysis of the study, which included 65 subjects, 39 percent of whom used alcohol, this difference was not sustained at 6 or 9 months (NaarKing et al. 2008 ).
• Gilbert and colleagues (2008) ran domized 476 HIVinfected patients, 38 percent of whom reported risky drinking, to an MIbased "Video Doctor" intervention via laptop computer or a control group receiving usual care. The intervention resulted in decreased 30day illicit drug use, lower mean number of drug use days, and a modest reduc tion of unprotected sex at 3 and 6 months. However, no differences in alcohol use existed between the intervention and control groups.
• Sorensen and colleagues (2003) randomly assigned HIVinfected patients with drug dependence, 61 percent of whom reported current alcohol use, to 1 year of continuous case management or to a brief con tact (i.e., one HIV risk education session and printed information).
No differences were noted in alcohol outcomes at 6, 12, or 18 months.
• A study among HIVinfected youths compared the effects of 23 2hour group sessions and usual care on risk behaviors (Rotheram Borus et al. 2001 ). The investigators found no changes from baseline on a measure reflecting alcohol and marijuana use and no difference between the intervention and control groups.
RCTs Among Alcohol Users at HighRisk for HIV Infection
Two informative RCTs have been con ducted among alcohol drinkers at high risk for HIV infection. Morgenstern and colleagues (2007) performed a study with 198 highrisk, HIVnegative men who had sex with men and who were diagnosed with alcohol abuse or depen dence but were seeking to moderate their alcohol use. The investigators compared the effects of 12 weekly MI sessions augmented with CBT with 4 sessions of MI alone. Unexpectedly, the investigators found that the nonaug mented MI group had less drinking and fewer alcoholrelated drinking problems than the MIplusCBT group during the 12 weeks of the interven tion and that there were no significant differences at 12month followup. Thus, the addition of CBT to MI tech niques provided no additional benefit regarding alcohol outcomes and poten tially even diminished effects in this population. Subgroup analyses demon strated that the detrimental effect of augmentation occurred particularly in participants with a concomitant drug use disorder. Another RCT (Kalichman et al. 2008 ) compared a 3hour, skillsbased HIV and alcohol risk reduction group session with a 1hour HIV/alcohol information group session among 342 South Africans frequenting drinking establishments. In this study, the extended session resulted in decreases in alcohol use before sex and unpro tected intercourse at 3 month but not at 6 month followup. Moreover, intervention effects were stronger in participants drinking less at baseline.
Discussion
Given the high prevalence of unhealthy alcohol use among HIVinfected people and its associated adverse health conse quences, development of clinical and public health interventions that seek to address alcohol use and improve health outcomes in this population is a priority. In recognition of this, NIAAA, as early as 1996, issued a request for applications entitled "Developing AlcoholRelated HIV Preventive Interventions (AA-97 -03)." Since then, several studies have been published that describe clinical outcomes of interventions in this pop ulation. However, as this article has demonstrated, the literature on this important topic still is not extensive. A literature search revealed only four clinical intervention studies focusing exclusively on HIVinfected patients with current or past unhealthy alcohol use; five other clinical trials included and documented the alcohol use of some of their HIVinfected participants. Overall, the current state of research strongly suggests that although the problems related to alcohol in HIVinfected people are abundant, effective interven tions are few and new ones are urgently needed. Hence, addressing alcohol problems remains an important issue in HIV research.
Not only are studies among alcohol abusing, HIVinfected patients scarce, but the existing studies also yielded mixed results. Two of the four studies that specifically targeted HIVinfected people with alcohol problems showed improvement in drinking outcomes. Velasquez and colleagues (2009) demonstrated reduced drinking levels over 12 months after an intervention that included both MI and peer sup port. The intervention was particularly strong in reducing sameday drinking and sex, which compels further research on interventions targeting alcohol use at the time of HIV risk behaviors (Velasquez et al. 2009 ). Although the intervention types used in the study only were shown to be effective in a sample of men who have sex with men, they warrant study among other populations. In the other study, Aharanovich and colleagues (2006) demonstrated the feasibility of ongoing telephonebased interactive voice response and graphic feedback, which should inspire the inclusion of auto mated, tailored, ongoing intervention boosting as part of behavioral inter ventions. It is important to note, however, that both these studies had methodological limitations (e.g., sub stantial or differential loss to follow up, incomplete assessments) and their findings therefore are not definitive. Nevertheless, they provide some guidance for future more rigorous clinical trials.
The other two clinical trials (Parsons et al. 2007; Samet et al. 2005 ) among alcoholabusing HIVinfected people attempted to improve ART adherence. This is an appropriate target of alcohol intervention studies in this popula tion because medication adherence is of utmost importance for achieving good HIV disease outcomes, and alcoholusing patients have been doc umented to exhibit suboptimal ART adherence (Braithwaite et al. 2005; Chander et al. 2006; Conen et al. 2009; . The results of both of these trials are discouraging, however, because although they explicitly addressed both alcohol use and medication adherence, one study (Samet et al. 2005) found no impact on adherence, alcohol consumption, or any HIV outcome, and the other (Parsons et al. 2007 ) only detected shortlived improvements (i.e., they were evident at 3 months, but not at 6 months). Thus, these two highquality studies suggest that achieving clinically beneficial outcomes in HIVinfected people with alcohol problems is more difficult than has been the case with populations of HIVinfected without diagnosed unhealthy alcohol use (Amico et al. 2006; Simoni et al. 2006) . Among the latter group, RCTs to improve adherence that used inter ventions with a range of intensities did reveal improvements in adherence which were sustained for up to 12 months, as well as in HIV viral load and CD4 counts (Tuldra et al. 2000) . The difficulty of achieving positive benefits (e.g., improved ART adher ence) through interventions among HIVinfected people who have alcohol problems also is evidenced by the study by Kalichman and colleagues (2008) among drinkers who were not infected with HIV. The findings of that study suggest that, as in brief intervention studies, intervention effectiveness varies by severity of alcohol use, with less improvement noted in dependent than in nondependent drinkers. Thus, levels of alcohol consumption, alcohol use disorder severity, and alcohol related consequences are important covariates to be assessed and reported in HIV intervention studies.
A notable finding of this literature review was that as of 2009, no study of pharmacotherapy for alcohol dependence in HIVinfected patients had been published. This is surprising given that pharmacotherapy plays a major role in addressing the AIDS epidemic by improving outcomes of HIVinfected subjects. Moreover, some preclinical research has demon strated that naltrexone, an effective medication for alcohol dependence, inhibits alcoholmediated enhance ment of HIV infection (Wang et al. 2006 ) and may potentiate the anti HIV effects of antiretroviral medica tions (Gekker et al. 2001) . Therefore, testing the effectiveness of naltrexone and other medications in alcohol dependent HIVinfected patients is an important current research direction.
Two of the studies reviewed here that included HIVinfected patients among whom at least 10 percent currently used alcohol, targeted risky sexual behaviors rather than alcohol consumption. Assessing treatment effects on sex risk factors is appropriate for studies among HIVinfected drinkers because several studies have demonstrated an association between alcohol use and risky sex (Purcell et al. 2001; Stein et al. 2009 ). In both the study by Gilbert and colleagues (2008) and the study by NaarKing and colleagues (2006, 2008) , sex risk behaviors were decreased in the group randomized to the intervention at 3 and 6 months, but there were no or only transient effects on alcohol use. These findings suggest that behavioral interventions which are not specifically tailored to address alcohol use are unlikely to impact alcohol problems in a sustained fashion.
The dearth of studies focusing on alcohol consumption among HIV infected people is understandable. Although the spectrum of unhealthy alcohol use ranging from risky use to alcohol dependence occurs in this population, other pressing health concerns (e.g., ART adherence, risky sexual behaviors, or engagement in HIV care) appropriately become the main focus of clinical trials that also may address alcohol consumption in their intervention arms. Developing interventions that target a specific behavior (e.g., sex) at the time of alcohol use is a worthy pursuit, and understanding the importance of decreasing alcohol use in order to suc cessfully achieve behavior change is cru cial for developing future interventions.
One interesting development noted in the studies reviewed here was the use of new technology (e.g., interac tive voiceresponse systems) in two of the studies (Aharonovich et al. 2006; Gilbert et al. 2008) . These approaches to delivering a behavioral intervention merit further exploration because they have the potential for providing scalable, ongoing delivery of tailored automated messages that may boost a more intensive directly administered intervention.
When assessing the relevance of the studies reviewed here, particularly those conducted among HIVinfected patients with past or current unhealthy alcohol use, it is important to consider the methodological quality of the work (i.e., the potential for bias, design limitations, and outcome measures). The report by Velasquez and col leagues (2009) is the only controlled study demonstrating a sustained clini cally significant treatment effect on an alcoholspecific outcome, making publication bias (i.e., the preferential publication of studies that find signif icant differences) unlikely.
Regarding their design, most, but not all, of these studies met important design criteria, such as random allo cation of participants to treatment groups and intentiontotreat analyses 6 in the presentation of results. As with all behavioral intervention studies, keeping participants in the dark about which treatment they receive (i.e., blinding of participants to their treat ment) is not possible. However, both Parsons and colleagues (2007) and Gilbert and colleagues (2008) utilized time and contentequivalent controls to allow for the detection of effects 6 An intentiontotreat analysis is based on the initial treatment intent, not on the treatment actually administered. Thus, every participant who begins the treatment is considered to be part of the trial, whether they finish it or not. This is done to avoid vari ous misleading artifacts that can arise in a study. For example, if participants who have a more serious problem tend to drop out at a higher rate, even an ineffective treatment may appear to provide benefits if one only compares the condition before and after the treatment among participants who finish the treatment and ignores participants who were enrolled originally but did not finish the treatment.
specific to the counseling method studied.
The outcome measures reported were not consistent across studies and not always meaningful, limiting the comparability of study outcomes. For example, NaarKing and colleagues (2006) used an alcoholspecific mea sure-the number of drinks per week during the week with the maximum number of drinks at 3 months-that is not widely used and of question able clinical meaning. Sorensen and colleagues (2003) only report a measure called the Addiction Severity Index Alcohol Composite Score, without any explanation or reporting of the individual components, complicating judgment of its clinical meaning. Finally, Samet and colleagues (2005) focused on ART adherence as an out come, yet this study may underesti mate the effectiveness of the interven tion because the criteria for eligibility to participate in the study did not exclude patients with already good adherence. Thus, participants with good adherence at baseline provided lit tle opportunity for an intervention to reveal a clinically meaningful impact.
In summary, as of 2009 the med ical literature on clinical trials focused on people with HIV infection and unhealthy alcohol use is limited (i.e., "drops in a bottle"). Few of these studies were able to document improved outcomes, and any effects observed generally were modest and transitory. Based on these findings and current knowledge, the following questions need to be addressed:
• What are the characteristics of interventions that mitigate the health consequences of alcohol use in HIVinfected people?
• How does the treatment setting impact the effectiveness of behavioral interventions?
• How can technology best be used to extend and enhance intervention effects?
• What characteristics of HIV infected drinkers suggest greater challenges when attempting to improve clinical outcomes?
• How can individual, network, or community interventions in people with multiple overlapping prob lems, including alcohol use, opti mally reduce unhealthy behaviors?
• How might combined pharma cotherapy and behavioral therapy be utilized to address the spectrum of clinical consequences that accom pany heavy alcohol consumption?
Obtaining answers to these ques tions is the key next step in the suc cessful development of clinical and public health interventions to mitigate the adverse outcomes from alcohol use in HIVinfected patients. ■ 
